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Viral myocarditis is an important human disease, and reovirus-induced myocarditis in mice provides an excellent model to
study direct viral damage to the heart. Previously, we showed that reovirus induction of and sensitivity to interferon- (IFN-)
is an important determinant of viral pathogenicity in the heart and that the transcription factor interferon regulatory factor-3
(IRF-3) is required for reovirus induction of IFN- in primary cardiac myocyte cultures. Given several lines of evidence
suggesting a possible distinctive environment for IRFs in the heart, we have now focused on IRF-1. Previous studies
demonstrated that viruses, double-stranded-RNA (dsRNA), and IFN-/ can each induce IRF-1 and that IRF-1 plays a role in
dsRNA, but perhaps not viral, induction of IFN-/. Importantly, none of these studies used a virus with a dsRNA genome
(such as reovirus), none of them used a highly differentiated nonlymphoid cell type, and none of them addressed whether viral
induction of IRF-1 is direct or is mediated through viral induction of IFN-. Indeed, as recently as this year it has been
assumed that viral induction of IRF-1 is direct. Here, we found that reovirus induced IRF-1 in primary cardiac myocyte
cultures, but that IRF-1 was not required for reovirus induction of IFN-. Surprisingly, we found that reovirus failed to induce
IRF-1 in the absence of the IFN-/ response. This provides the first evidence that viruses may not induce IRF-1 directly.
Finally, nonmyocarditic reovirus strains induced more cardiac lesions in mice deficient for IRF-1 than they did in wildtype
mice, directly demonstrating a protective role for IRF-1. Together, the results indicate that while IRF-1 is downstream of the
IFN- response, it plays an important protective role against viral myocarditis. © 2002 Elsevier Science (USA)iral myINTRODUCTION
Viral myocarditis affects an estimated 5–20% of the
human population (Woodruff, 1980). Many viruses have
been implicated in this disease (Woodruff, 1980), with
enteroviruses and adenoviruses most likely accounting
for the majority of cases (Martin et al., 1994). Enterovirus-
induced myocarditis is both immune-mediated (Cook et
al., 1995; Rose and Hill, 1996) and due to direct cyto-
pathic effect (Chow et al., 1992; Herzum et al., 1994),
while adenovirus-induced myocarditis is most likely not
immune-mediated (Martin et al., 1994). Given that many
viruses gain access to the heart, and that cardiac myo-
cytes are not replenished, the innate response of cardiac
cells to viral insult may well be a significant determinant
of cardiac damage. Reovirus-induced myocarditis is not
immune-mediated (Sherry et al., 1993, 1989), but instead
reflects virally induced apoptosis (DeBiasi et al., 2001)
and thus provides a unique model for investigating the
cardiac response to viral infection.
Previously, we found that in primary cardiac myocyte
cultures, nonmyocarditic reoviruses induce more inter-
feron- (IFN-) and are more sensitive to the antiviral
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20effects of IFN-/ than myocarditic reoviruses (Sherry et
al., 1998). In addition, nonmyocarditic reoviruses induce
myocarditis in mice pretreated with anti-IFN-/ anti-
body (Sherry et al., 1998). Thus, IFN- is an important
determinant of reovirus-induced myocarditis. Interestingly,
addition of anti-IFN-/ antibody inhibits reovirus spread in
primary cardiac myocyte cultures, but not in differentiated
C2C12 (skeletal muscle) cells (Sherry et al., 1998), suggest-
ing a possible unique role for IFN in the heart.
IFN- transcription is regulated by multiple positive
and negative regulatory factors in the cell. Viruses can
induce or activate many of these factors, and the critical
roles for the transcription factors interferon regulatory
factor-3 (IRF-3) and IRF-7 have been described exten-
sively (reviewed in Taniguchi et al., 2001). Interestingly,
IRF-3 is required for viral induction of IFN- in primary
cardiac myocyte cultures but not in the undifferentiated
L929 cell line (Noah et al., 1999). The related interferon
regulatory factor, IRF-1, is not normally expressed signif-
icantly in the brain, liver, or many other tissues, but is
constitutively expressed in the heart (Miyamoto et al.,
1988). Given the critical role of IFN- in mediating pro-
tection against reovirus myocarditis, and given these
precedents suggesting a unique environment for IRFs inKey Words: reovirus; double-stranded RNA (dsRNA); v
regulatory factor (IRF).
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the heart, we investigated the interplay between IRF-1,
IFN-, and reovirus-induced myocarditis.
IRF-1 binds to the interferon regulatory factor element
(IRF-E) in the IFN- regulatory region (Fujita et al., 1988).
Overexpression of IRF-1 may induce IFN- and IFN- in
the absence of viral infection (Fujita et al., 1989a) or may
require virally induced phosphorylation for activation (Lin
and Hiscott, 1999; Watanabe et al., 1991). Studies sug-
gest that while IRF-1 can modulate viral induction of
IFN-, it is not required. Specifically, depletion of IRF-1
decreases Newcastle disease virus induction of IFN-
(Reis et al., 1992). Newcastle disease virus, however,
induces IFN- in IRF-1/ mice (Reis et al., 1994), IRF-1/
embryonic stem cells (Ruffner et al., 1993), and IRF-1/
embryonic fibroblasts (Matsuyama et al., 1993; Reis et
al., 1994). Interestingly, in these same studies, dsRNA
induction of IFN- is impaired in IRF-1/ embryonic
fibroblasts (Matsuyama et al., 1993), suggesting that viral
infection and dsRNA may use distinct pathways for in-
duction of IFN-. This is particularly relevant when in-
vestigating reovirus induction of IFN- as the viral ge-
nome is composed of dsRNA (Nibert et al., 1996). Thus,
the role of IRF-1 in viral induction of IFN- may be
virus-specific. Moreover, no previous studies have ad-
dressed the role of IRF-1 in the induction of IFN- in
differentiated cells.
IRF-1 is both virus and IFN inducible (Fujita et al.,
1989b; Miyamoto et al., 1988). The similarity between
IRF-Es and interferon-stimulated response elements
(ISREs) would predict IRF-1 induction of interferon-stim-
ulated genes. Indeed, overexpressed IRF-1 can provide
antiviral protection even in the absence of IFN- function
(Pine, 1992). Thus, IRF-1 may play critical roles both
upstream and downstream of IFN- transcription. Sur-
prisingly, despite longstanding evidence that viruses in-
duce IRF-1 (Harada et al., 1989; Miyamoto et al., 1988;
Nakaya et al., 2001; Ronnie et al., 1995; Takeuchi et al.,
1998; Tsutsumi et al., 1999), no one has asked whether
this is a direct effect of the virus or is instead mediated
by virally induced IFN.
Here, we report that reovirus induces IRF-1 in primary
cardiac myocyte cultures, but that IRF-1 is not required
for reovirus induction of IFN- in these cells. Surprisingly,
reovirus fails to induce IRF-1 in the absence of IFN-/
function. This provides the first evidence that viral induc-
tion of IRF-1 may be mediated through viral induction of
IFN-. Last, reovirus-induced cardiac damage is in-
creased in IRF-1/ neonatal mice. Together, the data
indicate that while IRF-1 is downstream of IFN-, it plays
an important protective role against viral myocarditis.
RESULTS
Reovirus induces IRF-1 in primary cardiac myocyte
cultures
To determine if reovirus infection induces IRF-1 in the
heart, de novo protein synthesis was monitored in pri-
mary cardiac myocyte cultures (Fig. 1). Immunoprecipi-
tation of 35S-Met-labeled whole cell extracts revealed de
novo synthesis of IRF-1 in mock-infected cultures, con-
sistent with published data indicating constitutively high
expression of IRF-1 in the heart (Miyamoto et al., 1988).
There was a statistically significant 1.3-fold increase in
IRF-1 expression at 12 h postinfection with T3D, a non-
myocarditic reovirus that induces IFN. To determine if
reovirus could transcriptionally upregulate IRF-1, mRNA
was examined by Northern analysis (Fig. 2). Primary
cardiac myocyte cultures were either mock infected or
infected with T3D. Poly(A) RNA was extracted and sub-
jected to Northern analysis using a riboprobe specific for
IRF-1 or -actin. As previously reported (Miyamoto et al.,
1988), IRF-1 mRNA was expressed constitutively in
mock-infected cardiac cells. However, there was a 2.3-
fold (quantification of gel in Fig. 2) and a 1.5-fold (data not
shown) induction of IRF-1 at 14 h postinfection when
normalized to -actin.
The mechanisms of IRF-1 transcriptional regulation
were further examined using a luciferase reporter, pIRF-1
lux, which contains approximately 500 bp of the 5-
regulatory region of the murine IRF-1 gene inserted up-
stream of a firefly luciferase reporter gene. Primary car-
diac myocyte cultures were transfected with pIRF-1 lux
and a plasmid constitutively expressing renilla luciferase
for normalization. Cells were then either mock or virally
infected, and normalized luciferase activity was ana-
lyzed. In contrast to control plasmid (pGL3-C) that
showed no increase in activity (Fig. 3A), T3D induced
pIRF-1 lux at 8, 11, and 14 h postinfection 1.2- to 1.6-fold
FIG. 1. Reovirus induces IRF-1 in primary cardiac myocyte cultures.
Cr:NIH(S) primary cardiac myocyte cultures were metabolically labeled
with 35S-Met and either mock- or T3D-infected. Cell extracts were prepared
at the indicated time postinfection. IRF-1 was immunoprecipitated and
analyzed by gel electrophoresis. Duplicate wells are shown for T3D-
infected cultures at 9, 10.5, and 12 h.p.i. or mock-infected cultures at
12 h.p.i. The far right lane shows approximate molecular weights from a
prestained marker. Gels were dried and scanned for quantification of
IRF-1-specific bands (bottom). An asterisk denotes a significant increase
between mock- and virus-infected cultures (P  0.05).
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(Figs. 3A and 3B), consistent with T3D induction of pro-
tein (Fig. 1) and mRNA (Fig. 2) in these cultures.
IRF-1 induces IFN-, but is not required for viral
induction of IFN- in primary cardiac myocyte
cultures
Since IRF-1 is a transcriptional activator of IFN- (Fu-
jita et al., 1989a), we next determined whether IRF-1
induces IFN- in primary cardiac myocyte cultures by
using a luciferase reporter, plux, which contains the
IFN- regulatory region inserted upstream of a firefly
luciferase reporter gene. We cotransfected primary car-
diac myocyte cultures with plux and either a plasmid
constitutively expressing murine IRF-1 (mIRF-1) or a con-
trol plasmid (pRc/CMV2). We then analyzed normalized
luciferase activity. In contrast to the control plasmid that
showed no increase in activity, overexpressed IRF-1 in-
duced plux 4.1-fold (Fig. 4). Therefore, IRF-1 can induce
IFN in these cardiac cells.
Using an IFN bioassay and RT–PCR, we demonstrated
that reoviruses induce IFN- in primary cardiac myocyte
cultures (Sherry et al., 1998). Consistent with our previ-
ous results (Noah et al., 1999), T3D induced an IFN-
reporter construct 3.3-fold in these cultures (Fig. 5A). To
determine whether IRF-1 was required for T3D induction
of IFN- in primary cardiac myocyte cultures, we com-
pared T3D induction of plux in cultures generated from
IRF-1/ mice to cultures generated from wildtype paren-
tal C57BL/6J and 129Sv/Ev strains. T3D infection resulted
in an approximate 3-fold induction of plux in both
129Sv/Ev and C57BL/6J primary cardiac myocyte cul-
tures (Fig. 5B) and a similar 4.1-fold induction in IRF-1/
cultures (Fig. 5C). Therefore, IRF-1 is not required for viral
induction of IFN- in primary cardiac myocyte cultures.
Reovirus does not induce IRF-1 in primary cardiac
myocyte cultures in the absence of IFN-/ function
Viral infection or addition of IFN-/ to certain cell
types can induce IRF-1 (Fujita et al., 1989b; Miyamoto et
al., 1988). Despite this association, no one has asked
whether viral induction of IRF-1 is direct or is mediated
FIG. 2. Reovirus transcriptionally upregulates IRF-1 mRNA in primary
cardiac myocyte cultures. Cr:NIH(S) primary cardiac myocyte cultures
were either mock- or T3D-infected. Poly(A) mRNA was extracted
14 h.p.i. and electrophoresed on a formaldehyde denaturing gel. North-
ern analysis revealed a band approximately 2.1 kb after hybridizing with
an IRF-1 riboprobe (left). The IRF-1 probe was removed and the mem-
brane was rehybridized with a -actin probe, revealing a band at
approximately 1.9 kb and another at 1.3 kb, corresponding to -actin
and -actin, respectively (right). The far right lane shows approximate
molecular weights; V, viral; M, mock.
FIG. 3. Reovirus induces an IRF-1 reporter construct. Primary cardiac
myocyte cultures generated from Cr:NIH(S) mice were transfected with
the indicated plasmid and the normalization plasmid pRL-SV40. One
day posttransfection, the cultures were mock-infected (o) or infected
with reovirus T3D (). Luciferase activity was measured 14 h.p.i. (A)
and at 8, 11, and 14 h.p.i. (B). For each well, normalized luciferase
activity was determined by dividing firefly luciferase activity by renilla
luciferase activity. Each bar shows the mean of three wells ( the
standard error of the mean). Asterisks denote a significant increase
between mock- and virus-infected cultures (A, P  0.001; B, at 8 h P 
0.006, at 11 h P  0.001, at 14 h P  0.003).
FIG. 4. Murine IRF-1 induces IFN-. Primary cardiac myocyte cul-
tures generated from Cr:NIH(S) mice were transfected with plux, the
normalization plasmid pRL-SV40, and either control (pRc/CMV2) or
murine IRF-1 (mIRF-1) effector plasmid. Cells were mock-infected 1 day
posttransfection, and luciferase activity was measured 14 h.p.i. For
each well, normalized luciferase activity was determined by dividing
firefly luciferase activity by renilla luciferase activity. Each bar shows
the mean of three wells ( the standard error of the mean). Similar
results were obtained in replicate experiments. The asterisk denotes a
significant increase between cultures transfected with pRc/CMV2 and
murine IRF-1 (P  0.01).
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through viral induction of IFN-/, in any cell type. We
found that addition of IFN-/ to Cr:NIH(S) primary car-
diac myocyte cultures did not induce a control plasmid
(pGL3-C, Fig. 6A), but induced IRF-1 at multiple time
points (Fig. 6B). T3D induced IRF-1 1.5-fold in 129Sv/Ev
myocyte cultures as well (Fig. 7A). While induction was
apparent in cells treated with preimmune antibody, ad-
dition of anti-IFN-/ antibody decreased viral induction
of IRF-1 significantly. Some residual viral induction of
IRF-1 remained, however, and similar results were ob-
tained in Cr:NIH(S) cultures (data not shown). To deter-
mine whether this effect was due to insufficient antibody
or due to direct induction by the virus, viral induction of
IRF-1 was examined in primary cardiac myocyte cultures
generated from IFN-/ receptor/ mice. While T3D
induced IRF-1 1.5-fold in cultures generated from the
parental wildtype 129Sv/Ev mice, T3D failed to induce
IRF-1 in cultures from mice lacking the IFN-/ receptor
(Fig. 7B). Therefore, most, if not all, viral induction of IRF-1
is through IFN-.
Nonmyocarditic reoviruses can induce myocarditis in
IRF-1/ neonatal mice
Last, to investigate the role of IRF-1 in vivo, neonatal
mice were injected with two different reoviruses. Reovi-
FIG. 6. Treatment with type 1 IFN induces IRF-1 in primary cardiac
myocytes. Primary cardiac myocytes were transfected with the control
plasmid pGL3-C (A) or pIRF-1 lux (B) and the normalization plasmid
pRL-SV40. One day posttransfection, the cultures were mock-treated
(o) or treated with IFN-/ (^). Luciferase activity was measured at
14 h posttreatment (A) and at 8, 11, and 14 h posttreatment (B). For each
well, normalized luciferase activity was determined by dividing firefly
luciferase activity by renilla luciferase activity. Each bar shows the
mean of three wells ( the standard error of the mean), with the
exception of the pIRF-1 lux bar in A, which shows the mean of four wells
( the standard error of the mean). Asterisks denote a significant
increase between mock- and IFN-treated cultures (A, right P  .036; B,
from left to right, P  0.001; P  0.001; P  0.001).
FIG. 5. IRF-1 is not required for viral induction of IFN-. Primary
cardiac myocyte cultures generated from Cr:NIH(S) mice (A), from
C57BL/6J mice (B, left), from 129Sv/Ev mice (B, right), or from IRF-1
(/) mice (C) were transfected with control plasmid (PGL3-C) or
plux and the normalization plasmid pRL-SV40. One day posttransfec-
tion, the cultures were mock-infected (o) or infected with reovirus T3D
(). Luciferase activity was measured 14 h.p.i. For each well, normal-
ized luciferase activity was determined by dividing firefly luciferase
activity by renilla luciferase activity. Each bar shows the mean of three
wells ( the standard error of the mean). Asterisks denote a significant
increase between mock- and virus-infected cultures (A, P  0.001; B
left, P  0.003; B right, P  0.048; C, P  0.001).
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rus 8B is potently myocarditic in mice, while reovirus
DB95 characteristically induces no or few cardiac le-
sions. Mice were injected with the dose of virus indi-
cated, and at 7 days postinjection, cardiac sections were
prepared, stained with hematoxylin and eosin, and ex-
amined for microscopic lesions (Fig. 8). As expected, 8B
induced a large number of lesions in 129Sv/Ev wildtype
and IRF-1/ strains (experiments not performed in
C57BL/6J mice). In contrast, while DB95 induced few or
no lesions in both 129Sv/Ev and C57BL/6J wildtype pa-
rental mice, the virus induced many lesions in mice
lacking IRF-1. Similar results were obtained using a
higher dose of DB95 (3  106 PFU; data not shown).
Thus, IRF-1 is protective against viral myocarditis.
DISCUSSION
IFN- is a significant determinant of reovirus-induced
myocarditis (Sherry et al., 1998). IRF-3 and IRF-7 have
been shown to be critical in the viral induction of IFN-
(Noah et al., 1999; Sato et al., 2000; Taniguchi et al., 2001;
Wathelet et al., 1998). Evidence for IRF-1 regulation of
IFN- has been less straightforward, with data suggest-
ing that IRF-1 can regulate (Reis et al., 1992), but is not
required for (Matsuyama et al., 1993; Reis et al., 1994;
Ruffner et al., 1993), viral induction of IFN-. Those stud-
ies, however, used a virus with a single-stranded RNA
genome (Newcastle disease virus), and they investi-
gated only undifferentiated cells. Moreover, the same
studies demonstrated that dsRNA induction of IFN- is
impaired in the absence of IRF-1 (Matsuyama et al.,
1993). It was thus unclear whether a virus with a double-
stranded RNA genome, reovirus, would utilize IRF-1 for
IFN- induction and whether IRF-1’s role might be al-
tered in differentiated cells. In addition, since the heart
has higher constitutive levels of IRF-1 mRNA than other
tissues examined (Miyamoto et al., 1988), it was unclear
whether cardiac cells would provide a unique environ-
ment for IRF-1 function. Finally, our previous evidence
that IRF-3 functions differently in cardiac cells than in
L929 cells for viral induction of IFN- (Noah et al., 1999)
suggests that the heart may provide a unique require-
FIG. 8. IRF-1 can protect against viral myocarditis. C57BL/6J (s),
129Sv/Ev (o), or IRF-1/ () neonatal mice were inoculated intramus-
cularly with either 1  103 PFU of reovirus strain 8B (myocarditic;
C57BL/6J not injected) or 5  105–1  106 PFU of reovirus strain DB95
(nonmyocarditic). At 7 days postinjection, blinded H&E-stained cardiac
sections were examined for microscopic lesions utilizing morphometric
analysis. Percentage of lesion refers to the average area of lesion
divided by the average total area  100  standard error of the mean.
The asterisk denotes a significant increase between DB95-infected
C57BL/6J, 129Sv/Ev, or IRF-1/ mice; P  0.05 for C57BL/BJ vs
IRF/; P  0.005 for 129Sv/Ev vs IRF-1/.
FIG. 7. Viral induction of IRF-1 is through virally induced IFN-.
Primary cardiac myocyte cultures generated from 129Sv/Ev or IFN-/B
receptor (/) mice were transfected with pIRF-1 lux and the normal-
ization plasmid pRL-SV40. The cells were mock-infected (o) or infected
with reovirus T3D () 1 day postransfection. In A, 1100 neutralizing
units/ml of anti-IFN-/ or preimmune antibody was added to the wells
with overlay media immediately following infection. Luciferase activity
was measured 14 h.p.i. For each well, normalized luciferase activity
was determined by dividing firefly luciferase activity by renilla lucif-
erase activity. Each bar shows the mean of three wells ( the standard
error of the mean). Similar results were obtained in replicate experi-
ments. In A (left), the asterisk denotes a significant increase between
preimmune-treated cultures mock- or T3D-infected; P  0.03. In A
(middle), the asterisk denotes a significant decrease between infected
cultures treated with preimmune or anti-IFN antibody; P  0.03. In A
(right), the asterisk denotes a significant increase between anti-IFN-
/ antibody-treated cultures, mock- or T3D-infected; P  0.01. In B
(left), the asterisk denotes a significant increase between cultures
mock- or T3D-infected; P  0.011.
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ment for IRFs in general. We show here that reovirus
induces IRF-1 in primary cardiac myocyte cultures and
that overexpressed IRF-1 induces IFN- in those cul-
tures. Using primary cardiac myocyte cultures derived
from IRF-1/ mice, however, we show that reovirus in-
fection induces IFN- in the absence of IRF-1. Together
these data suggest that while IRF-1 is not required for
viral induction of IFN- in the heart, IRF-1 can modulate
IFN- expression there.
Using primary cardiac myocyte cultures derived from
IFN-/ receptor/ mice, we have found that most, if not
all, reovirus induction of IRF-1 is mediated through virally
induced IFN-. Despite numerous reports of virally in-
duced IRF-1 (Harada et al., 1989; Miyamoto et al., 1988;
Nakaya et al., 2001; Ronnie et al., 1995; Takeuchi et al.,
1998; Taniguchi et al., 2001; Tsutsumi et al., 1999), the
possibility that this could be an indirect effect had not
previously been addressed. While most investigators as-
sumed that viral induction of IRF-1 is a direct effect of the
virus, results here provide the first evidence that viruses
may not induce IRF-1 directly. Recent studies describe
the complexity of the IFN response, requiring both the
initial direct virus activation of IRF-3 for initial IFN induc-
tion and subsequent IFN induction of IRF-7 for a full IFN
response (Sato et al., 2000; Taniguchi et al., 2001; Wathe-
let et al., 1998). Our results indicate that virus induction of
IRF-1 is not direct, but rather, like that of IRF-7, is medi-
ated by viral induction of IFN. IRF-1 may have a second
important similarity to IRF-7: maximal induction of IFN
requires IFN-induced IRF-7, and maximal IFN induction of
interferon-stimulated genes may require IFN-induced
IRF-1 (see below). Future studies will address whether
the requirement for IFN- in virus induction of IRF-1 is
unique to reovirus or cardiac cells or whether it is com-
mon to many viruses and cell types.
The IRF-1 regulatory region contains an IFN- activa-
tion sequence (GAS) (Harada et al., 1994; Sims et al.,
1993) and a binding site for NF-B (Sims et al., 1993). The
mechanism by which IFN- induces IRF-1 is likely
through the formation of STAT1–STAT2 heterodimers (Li
et al., 1996). While IFN- induction of antiviral genes
through the JAK–STAT pathway has been well-character-
ized, IFN- induction of IRF-1 may provide additional
critical induction of these same genes. Indeed, IFN’s
antiviral effects can be impaired in IRF-1/ cells (Kimura
et al., 1994). IRF-1 has been shown to bind in monomeric
and dimeric form (Kirchhoff et al., 1998; Spink and Evans,
1997) to several ISREs, and IRF-1 has been shown to
regulate transcription of the antiviral gene PKR (Beretta
et al., 1996; Nguyen et al., 1997), the antiviral gene 2-5
oligo A synthetase (Coccia et al., 1999; Reis et al., 1992),
and major histocompatibility genes (Hobart et al., 1997;
Lefebvre et al., 2000). These data suggest that IRF-1 may
be important for maximal IFN induction of interferon-
stimulated genes. Interestingly, reovirus-infected human
thyroid follicular cells show enhanced MHC I expression
through virally induced IFN (Atta et al., 1995), and one
possible mechanism could be through IRF-1. Given that
reovirus infection activates PKR (Gupta et al., 1982) and
2-5 oligo A synthetase (Nilsen et al., 1982b) and that
these genes have been implicated in inhibiting reovirus
replication (De Benedetti et al., 1985; Gupta et al., 1982;
Nilsen et al., 1982a; Samuel et al., 1984) a possible
antiviral role for IRF-1 as a direct inducer of these inter-
feron-stimulated genes is difficult to ignore.
In neonatal mice, reovirus-induced cardiac lesions
were increased in the absence of IRF-1, demonstrating
its protective role against myocarditis. IRF-1 has been
shown to play a similar protective role against Venezu-
elan equine encephalitis virus (Grieder and Vogel, 1999)
and encephalomyocarditis virus (Kimura et al., 1994).
Replication of vesicular stomatitis virus and herpes sim-
plex virus in embryonic fibroblasts, however, is unaf-
fected by the absence of IRF-1 (Kimura et al., 1994). Thus
the antiviral role of IRF-1 may be virus- and cell type-
specific. The increased cardiac lesions here in reovirus-
infected IRF-1/ mice most likely reflect increased viral
replication and could be due to a number of possible
mechanisms. These mice are deficient in natural killer
(NK) cell function (Duncan et al., 1996), an early compo-
nent of the host response to infection which has been
shown to protect against Coxsackie virus-induced myo-
carditis (Godeny and Gaunt, 1986). IRF-1/ mice also
have decreased numbers of CD8 T cells (White et al.,
1996). Nonmyocarditic reoviruses, however, remain non-
myocarditic in mice lacking CD8 T cells (Sherry et al.,
1993, 1989), suggesting that increased cardiac lesions in
IRF-1/ mice do not reflect deficient CD8 T cell func-
tion. A similar argument can be made for the proposed
critical role for IRF-1 in B cell activation (Gupta et al.,
1998), in that nonmyocarditic reoviruses remained non-
myocarditic in mice lacking B cells (Sherry et al., 1993).
Finally, IRF-1 may play a critical role in induction of
ISREs, as discussed above, and regulates other antiviral
genes containing IRF-Es. For example, inducible nitric
oxide synthase (iNOS) is regulated by IRF-1 (Kamijo et al.,
1994) in many cells, including cardiac myocytes (Bach-
maier et al., 1997), and has been shown to inhibit the
replication of both avian reovirus (Pertile, 1996) and Cox-
sackie B virus-induced myocarditis (Lowenstein et al.,
1996). Thus, IRF-1’s protective role may reflect regulation
of antiviral genes (containing ISREs or IRF-Es), or im-
mune cells, or both. Future studies will address the
downstream effectors of the IRF-1 protective response.
MATERIALS AND METHODS
Viruses
Reovirus stocks were characterized previously for
their myocarditic phenotypes (Sherry and Blum, 1994;
Sherry and Fields, 1989). Serotype 3 Dearing (T3D) is a
prototype strain that is nonmyocarditic (Sherry et al.,
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1989) and induces IFN- (Sherry et al., 1998). Reovirus 8B
is a reassortant virus that is potently myocarditic (Sherry
et al., 1989) and induces IFN- poorly (Sherry et al.,
1998). Reovirus DB95 is a reassortant virus that is non-
myocarditic (Sherry and Fields, 1989) and induces IFN-
(Sherry et al., 1998).
Mice and inoculations
Timed pregnant Cr:NIH(S) mice were obtained from
the National Cancer Institute. IRF-1/ mice were derived
as a hybrid of 129Sv/Ev and C57BL/6J genetic back-
grounds (Reis et al., 1994) and were generously provided
by Jenny Ting (University of North Carolina, Chapel Hill,
NC). IFN / receptor/ (Muller et al., 1994) and wild-
type parental 129Sv/Ev mice were generously provided
by Dr. Herbert W. Virgin IV (Washington School of Medi-
cine, St. Louis, MO). Wildtype C57BL/6J mice were gen-
erously provided by Dr. Bryan Williams (Cleveland Clinic
Foundation, Cleveland, OH). For inoculations with reovi-
rus, indicated mice were mated, housed individually in
isolator cages, and checked daily for births. Neonates (2
days old) were inoculated in the left hind limb with 20 l
of virus diluted with gel saline (8B, 1.0  103 PFU; DB95,
5.0  105–1.0  106 PFU). At 7 days postinjection, mice
were euthanized. Hearts were removed and fixed in 10%
buffered Formalin, sectioned, and stained with hematox-
ylin and eosin (H&E). Blinded slides (3 hearts per virus
dose, and 5 to 6 sections per heart) were analyzed for
lesions utilizing a Olympus Vanox workstation with mor-
phometric software. Mice were housed according to
AAALAC recommendations and all procedures were ap-
proved by NCSU IACUC.
Cell cultures
To generate primary cardiac myocyte cultures from
Cr:NIH(S), 129Sv/Ev, IRF-1/, or IFN-/ receptor/
mice, term fetuses or 1-day-old neonates were sacrificed
and the apical two thirds of the hearts were removed,
minced, and trypsinized (Baty and Sherry, 1993). Cells
were plated at a density of 1.25  106 cells per well in
six-well clusters (Costar, Cambridge, MA) and incubated
for 1.5 to 2 h to remove rapidly adherent cells (predom-
inantly fibroblasts). The remaining cells (predominantly
myocytes) were resuspended in Dulbecco’s modified Ea-
gle’s medium (DMEM) (Gibco BRL, Gaithersburg, MD)
supplemented with 7% fetal calf serum (HyClone, Logan,
UT), 0.06% thymidine (Sigma Co., St. Louis, MO), and 10
g of gentamicin (Sigma) per milliliter (“supplemented
media”) and plated as indicated for each procedure.
Myocyte cultures contained 5–20% fibroblasts (Baty and
Sherry, 1993), consistent with levels reported by others
(Hamamori et al., 1990; Huber and Lodge, 1984; McDer-
mott et al., 1985) and consistent with cell heterogeneity in
the heart.
Plasmids
The plux reporter plasmid was constructed as previ-
ously described (Noah et al., 1999) and contains the
murine IFN- regulatory region inserted into pGL3-Basic
(Promega). The pIRF-1 lux reporter plasmid was con-
structed by using polymerase chain reaction (PCR) to
add KpnI and BglII restriction sites to bases 1 to 514
upstream of the murine IRF-1 coding region and inserting
the product into pGL3-Basic. Murine IRF-1 inserted into
pRc/CMV1 (Yim et al., 1997) was kindly provided by Dr.
Jerry Doherty (Washington School of Medicine, St. Louis,
MO). pRc/CMV2 was purchased (Invitrogen). pRL-SV40
(expressing renilla luciferase constitutively from an SV40
promoter), pGL3-Basic (lacking a promoter and therefore
expressing baseline firefly luciferase), and pGL3-Control
(expressing firefly luciferase constitutively from an SV40
promoter) were purchased (Promega). DNA was purified
for transfection using Qiagen’s Maxiprep system (Qiagen
Inc., Valencia, CA).
Transfections
Primary cardiac myocyte cultures were plated at a
density of 1.0  105 cells per well in 0.5 ml in 48-well
tissue culture plates from Costar (Figs. 4, 5A, 5B, 6A, and
7) or 3.5  105 cells per well in 1 ml in 12-well tissue
culture plates (Figs. 3, 5C, and 6B). All cultures were
allowed to adhere for 1 day prior to transfection. Trans-
fection was performed as previously described (Noah et
al., 1998, 1999) using FuGENE6 according to the manu-
facturer’s protocol (Boehringer Mannheim/Roche Molec-
ular Biomedicals, Indianapolis, IN). Transfection condi-
tions were optimized previously using a -galactosidase
reporter plasmid that demonstrated that myocytes in
primary cardiac myocyte cultures were transfected, al-
though overall transfection efficiency was low (Noah et
al., 1998). Unless noted otherwise in the figures, the
amount of DNA added to the indicated wells was as
follows in a 48-well cluster experiment: plux, 0.5 g;
pIRF-1 lux, 0.5 g; pRL-SV40, 0.01 g; pGL3-Control, 1.0
g; pRc/CMV2, 1.0 g; murine IRF-1 (mIRF-1), 1.0 g. The
DNA concentration was doubled for all plasmids in a
12-well cluster experiment. FuGENE6 was used in a
volume equal to twice the total micrograms of plasmid
DNA to be transfected per well (e.g., 2 g of plasmid
DNA per well required 4 l of FuGENE6 per well).
Infections
Infections were performed 1 day postransfection or
24 h postplating of cells (immunoprecipitation and RNA
extraction). Primary cardiac myocyte cultures were
washed twice with supplemented DMEM immediately
prior to infection. For transfections, two wells were
trypsinized and viable cells were counted using trypan
blue exclusion. Myocyte cultures for immunoprecipita-
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tion or RNA extraction were assumed to be at 50% their
plating densities, based on previous experience. For
transfected cultures in 12-well plates and cultures plated
for RNA and for immunoprecipitation, cells were infected
with reovirus T3D (Dearing) at 25 PFU per cell in 300 l
of supplemented media or were mock infected. Cultures
were incubated for 1 h at 37°C in 5% CO2. For transfected
cultures in 12-well plates and cultures plated for RNA,
700 l of supplemented DMEM was then added. Trans-
fected cultures plated in 48-well plates were treated
identically but with 50% less volume (150-l innoculum
and 350-l overlay volumes). Immediately following over-
lay, 1000 units/ml of IFN-/ (Sigma, Fig. 6A; Lee Biomo-
lecular, Fig. 6B) or 1100 neutralizing units/ml of anti-IFN-
/ or preimmune antibody (Access Biomedical, Fig. 7)
was added if indicated. Cells were incubated at 37°C
and 5% CO2 for times indicated.
Dual-luciferase assay
The dual-luciferase assay was performed according to
the manufacturer’s protocol (Promega) with the following
exceptions: cells were washed twice with phosphate-
buffered saline prior to the addition of lysis buffer, cells
were allowed to remain in lysis buffer at 4°C for at least
15 min, and the surfaces of the wells were then scraped
with either a Teflon cell lifter from Costar (12-well clus-
ters) or a rubber policemen from Fisher Scientific (48-
well clusters). Measurements were made using a Lumat
LB 9507 luminometer (EG&G Berthold, Oakridge, TN)
and autoinjection. Normalized luciferase activity was de-
termined by dividing firefly luciferase activity by renilla
luciferase activity. Normalized luciferase values varied
minimally between replicate wells within an experiment,
but varied significantly between experiments regardless
of cell type, reporter, or stimulus. This was likely due to
different stabilities of the renilla and firefly luciferase
substrates. Therefore, all conclusions based on compar-
isons between experiments relied on comparisons be-
tween “fold changes” rather than normalized luciferase.
Immunoprecipitation
Cr:NIH(S) primary cardiac myocyte cultures (plated at
8  105 cells per well in 12-well clusters and incubated
for 24 h) were infected as described above. After 1 h at
37°C in 5% CO2, cultures were washed twice with me-
thionine-free media and overlayed with 375 l of supple-
mented methionine-free media containing 40 Ci of
[35S]methionine trans-label (specific activity 10.5 mCi/ml).
At the indicated time postinfection, cultures were
washed twice with PBS and removed from plastic by
scraping with a Teflon cell lifter (Costar). Cells were then
microfuged at 3000 rpm, 4°C for 5 min. Pellets were
resuspended in 100 l of cell lysis buffer (50 mM Tris, pH
8, 150 mM NaCl, 1% NP-40) supplemented with 1 mM
phenylmethylsulfonyl fluoride (PMSF), 10 ng/l of leu-
peptin, 10 ng/l of pepstatin, and 1 mM DTT and sub-
jected to two freeze thaws. Samples were then mi-
crofuged at 13,000 rpm, 4°C, for 5 min. The resulting
supernatant was incubated with 100 l of a preequili-
brated 50% Sepharose CL4B (Pharmacia) slurry at 4°C
with gentle rocking for 3 h. Beads were allowed to
settle by gravity or were microfuged for 3 min, 4°C at
6000 rpm. Supernatant was incubated with 100 l (50%
slurry) of protein A–Sepharose beads (Pharmacia) prein-
cubated with 10 l of murine IRF-1 antibody (Santa Cruz
Biotech, Cat. No. SC-640 at 200 g/ml) per sample (equiv-
alent of 100 l of a 50% slurry) at 4°C with gentle rocking,
overnight. Beads were washed 4 with 6 packed bead vol
of lysis buffer supplemented with PMSF. Protein was eluted
with 50 l 2 Laemmli sample buffer and analyzed on a
10% SDS–polyacrylamide gel. Gel bands were quantified by
scanning dried gels on a Packard Instant Imager.
Northern analysis
Cr:NIH(S) primary cardiac myocyte cultures (plated at
2.0 106 cells per well in 24-well clusters and incubated
24 h) were infected as described. At 14 h postinfection,
supernatants were aspirated, and poly(A) mRNA was
isolated directly from cells in culture plates according to
the Oligotex Direct mRNA Protocol for Isolation of
poly(A) mRNA from Animal Cells (Qiagen), with the
exception that a syringe and needle were used instead
of a QIAshredder for homogenizing samples. According
to expected protocol yields, approximately 0.3–0.6 g of
T3D or mock-infected poly(A) mRNA was extracted and
electrophoresed on a formaldehyde denaturing gel
(Sherry et al., 1996), using Oligotex 5 RNA loading
buffer (Qiagen). RNA was transferred to nylon membrane
and UV-crosslinked. The nylon was incubated in a rolling
apparatus at 51°C for 1 h with 100 l/cm2 of prehybrid-
ization solution (5 SSPE, 50% formamide, 1% SDS, 5
Denhardt’s, and 100 g/ml of denatured salmon sperm
DNA). Riboprobe was generated from either the -actin
or murine IRF-1 template using Riboprobe Systems-T3
and -SP6, respectively (Promega). The blot was then
hybridized at 51°C for approximately 20 h with 20 l/cm2
of hybridization buffer identical to prehybridization buffer
but lacking salmon sperm DNA and containing 2000
cpm/l of the IRF-1 riboprobe. The nylon was subjected
to two room temperature 15-min washes with a 5
SSPE, 0.5% SDS solution to wash off unlabeled probe
and bands were quantified on a Packard Instant Imager.
The membrane was similarly hybridized with a -actin
riboprobe at 65°C and bands were again quantified. At
this temperature, the IRF-1 riboprobe was removed.
Statistical analysis
A Student’s one-tailed t test and pooled variance was
used for statistical analysis. Results were considered
significant at P  0.05.
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